The latest closing stock price for Aquestive Therapeutics as of January 31, 2025 is 3.02.
An investor who bought $1,000 worth of Aquestive Therapeutics stock at the IPO in 2018 would have $-812 today, roughly -1 times their original investment - a -21.23% compound annual growth rate over 7 years.
The all-time high Aquestive Therapeutics stock closing price was 18.96 on September 07, 2018.
The Aquestive Therapeutics 52-week high stock price is 6.23, which is 106.3% above the current share price.
The Aquestive Therapeutics 52-week low stock price is 2.24, which is 25.8% below the current share price.
The average Aquestive Therapeutics stock price for the last 52 weeks is 3.87.
An investor who bought $1,000 worth of Aquestive Therapeutics stock at the IPO in 2018 would have $-812 today, roughly -1 times their original investment - a -21.23% compound annual growth rate over 7 years.
The all-time high Aquestive Therapeutics stock closing price was 18.96 on September 07, 2018.
The Aquestive Therapeutics 52-week high stock price is 6.23, which is 106.3% above the current share price.
The Aquestive Therapeutics 52-week low stock price is 2.24, which is 25.8% below the current share price.
The average Aquestive Therapeutics stock price for the last 52 weeks is 3.87.